Impact of thoracic multidisciplinary tumor boards on the management of patients with cancer: A retrospective study at the American university of Beirut medical center

Kreidieh,Firas; Tfayli,Arafat

doi:10.3892/mco.2022.2602

Impact of thoracic multidisciplinary tumor boards on the management of patients with cancer: A retrospective study at the American university of Beirut medical center

Authors:
- Firas Kreidieh
- Arafat Tfayli
View Affiliations

Affiliations: Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1755 Wyndale St, Houston, Texas 77030, USA, Division of Hematology‑Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Beirut, Lebanon
Published online on: December 19, 2022 https://doi.org/10.3892/mco.2022.2602
Article Number: 6

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multidisciplinary tumor boards (MDT) provide an opportunity for experts from different specialties and expertise to pool and complement each other's experience and inputs. Several factors impact the MDT discussions, including the meeting's structure, time management, and expert leadership. The process of MDT, their utilization, and efficacy need continuous assessment and improvement. A retrospective study was conducted to review the process of thoracic MDT, their plans of therapy, and changes in diagnosis and treatment plans for patients with cancer at the American University of Beirut Medical Center (AUBMC) over the period of one year. The primary outcome measure was the percentage of patients presented at the thoracic MDT who had a change in their treatment plan after the presentation. A total of 214 cases were scheduled for thoracic MDT during the study period. The majority, 132 (61.7%) did not have a treatment plan before presenting in the MDT. Of the 195 cases presented, only 43 (22.0%) did not have a change in their plan, while 88 (45.2%) of the cases presented had a change in their treatment plan. A total of 64 (32.8%) cases consisted of discussion of the diagnosis during MDT with either confirmation or modification of the patients' diagnosis. Of the 195 cases that were presented, the majority, 170 (87.2%), had their recommended treatment plan implemented after the MDT discussion. There was an association between the stage of cancer at the time of presentation and requesting additional tests (P=0.021), but there was no association between the stage of cancer and change in treatment plan (P=0.177) nor with implementation of recommendation (P=0.217). MDT are used to make upfront management decisions. In addition to considering change in management plans as an indicator of the benefit of MDT, it is suggested that making upfront multidisciplinary plans shall be considered an additional component of indicators of the benefit of MDT.

View Figures

View References

1	El Saghir NS, Keating NL, Carlson RW, Khoury KE and Fallowfield L: Tumor boards: Optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Ed Book. e461–e466. 2014.PubMed/NCBI View Article : Google Scholar
2	Specchia ML, Frisicale EM, Carini E, Di Pilla A, Cappa D, Barbara A, Ricciardi W and Damiani G: The impact of tumor board on cancer care: Evidence from an umbrella review. BMC Health Serv Res. 20(73)2020.PubMed/NCBI View Article : Google Scholar
3	National Cancer Institute (NCI): Dictionary of Cancer Terms: Tumor Board Review. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-board-review.
4	Soukup T, Sevdalis N, Green JSA, Lamb BW, Chapman C and Skolarus TA: Making tumor boards more patient-centered: Let's start with the name. JCO Oncol Pract. 17:591–593. 2021.PubMed/NCBI View Article : Google Scholar
5	Chang JH, Vines E, Bertsch H, Fraker DL, Czerniecki BJ, Rosato EF, Lawton T, Conant EF, Orel SG, Schuchter L, et al: The impact of a multidisciplinary breast cancer center on recommendations for patient management: The University of Pennsylvania experience. Cancer. 91:1231–1237. 2001.PubMed/NCBI View Article : Google Scholar
6	Petty JK and Vetto JT: Beyond doughnuts: Tumor board recommendations influence patient care. J Cancer Educ. 17:97–100. 2002.PubMed/NCBI View Article : Google Scholar
7	Kehl KL, Landrum MB, Kahn KL, Gray SW, Chen AB and Keating NL: Tumor board participation among physicians caring for patients with lung or colorectal cancer. J Oncol Pract. 11:e267–e278. 2015.PubMed/NCBI View Article : Google Scholar
8	Wong BO, Blythe JA, Wu A, Batten JN, Kennedy KM, Kouaho AS and Wren SM: Exploration of clinician perspectives on multidisciplinary tumor board function beyond clinical decision-making. JAMA Oncol. 8:1210–1212. 2022.PubMed/NCBI View Article : Google Scholar
9	Dharmarajan H, Anderson JL, Kim S, Sridharan S, Duvvuri U, Ferris RL, Solari MG, Clump DA II, Skinner HD, Ohr JP, et al: Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience. Head Neck. 42:1310–1316. 2020.PubMed/NCBI View Article : Google Scholar
10	Blasi L, Bordonaro R, Serretta V, Piazza D, Firenze A and Gebbia V: Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews Among oncology centers in the COVID-19 Era: Protocol for an observational study. JMIR Res Protoc. 10(e26220)2021.PubMed/NCBI View Article : Google Scholar
11	El Saghir NS, Charara RN, Kreidieh FY, Eaton V, Litvin K, Farhat RA, Khoury KE, Breidy J, Tamim H and Eid TA: Global practice and efficiency of multidisciplinary tumor boards: Results of an American society of clinical oncology International survey. J Glob Oncol. 1:57–64. 2015.PubMed/NCBI View Article : Google Scholar
12	El Saghir NS, Farhat RA, Charara RN and Khoury KE: Enhancing cancer care in areas of limited resources: Our next steps. Future Oncol. 10:1953–1965. 2014.PubMed/NCBI View Article : Google Scholar
13	Mano MS, Çitaku FT and Barach P: Implementing multidisciplinary tumor boards in oncology: A narrative review. Future Oncol. 18:375–384. 2022.PubMed/NCBI View Article : Google Scholar
14	El Saghir NS, El-Asmar N, Hajj C, Eid T, Khatib S, Bounedjar A, Ajarim D, Shamseddine A, Geara F, Jazieh A, et al: Survey of utilization of multidisciplinary management tumor boards in Arab countries. Breast. 20 (Suppl 2):S70–S74. 2011.PubMed/NCBI View Article : Google Scholar
15	Schmidt HM, Roberts JM, Bodnar AM, Kunz S, Kirtland SH, Koehler RP, Hubka M and Low DE: Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: A prospective cohort study. Ann Thorac Surg. 99:1719–1724. 2015.PubMed/NCBI View Article : Google Scholar
16	Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN and McNeil BJ: Tumor boards and the quality of cancer care. J Natl Cancer Inst. 105:113–121. 2013.PubMed/NCBI View Article : Google Scholar
17	Charara RN, Kreidieh FY, Farhat RA, Al-Feghali KA, Khoury KE, Haydar A, Nassar L, Berjawi G, Shamseddine A and El Saghir NS: Practice and impact of multidisciplinary tumor boards on patient management: A prospective study. J Glob Oncol. 3:242–249. 2016.PubMed/NCBI View Article : Google Scholar
18	Snyder A, Kemeny N, Shamseddine A, Al-Olayan A, El-Merhi F, Kelsen DP, Jamali F, Sidani M, Mukherji D, El-Naghy M, et al: Liver-directed conversion therapy in metastatic colon cancer. J Gastrointest Oncol. 6:322–328. 2015.PubMed/NCBI View Article : Google Scholar
19	El Saghir N: ABC of Breast Diseases, Awareness, Prevention, Treatment (ed 3). Beirut, Lebanon, Arab Scientific Publishers,. 2013, pp 261-267, 2013. https://www.neelwafurat.com/itempage.aspx?id=lbb132751-92883&search=books.
20	Stevenson MM, Irwin T, Lowry T, Ahmed MZ, Walden TL, Watson M and Sutton L: Development of a virtual multidisciplinary lung cancer tumor board in a community setting. J Oncol Pract. 9:e77–e80. 2013.PubMed/NCBI View Article : Google Scholar
21	El Saghir NS, Charana R, Eaton VJ, Litvin K, Farhat R, Khoury K, Breidy J and Tamim H: ASCO Survey: Use and efficiency of multidisciplinary tumor boards worldwide. Ann Oncol. 25(iv373)2014.